iSpeechPathology.com – Call us: 800-242-5183
eLuma - Love What You Do - September 2025

Using the MoCA in a Home Healthcare Setting

Kim McCullough, Ph.D., CCC-SLP

March 5, 2013

Share:

Question

I work in a home healthcare setting.  Would the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) be a good tool to use at evaluation and then later at discharge to get improvement measures?

Answer

The MoCA would be a good screening measurement, but I do not think that the MoCA is the place that you should stop with your evaluation.  The MoCA only takes about 10 minutes to administer.  What I think is going to be important is that in the assessment procedures, we know exactly where those impairment areas are and whether it is a just a single domain or multiple domains.  That is going to direct your treatment.

Kim McCullough, Ph.D., CCC-SLP is an Associate Professor at the University of Central Arkansas (UCA). She has 17 years experience as a clinician, teacher, and researcher in the area of adult neurogenic communication disorders. 


kim mccullough

Kim McCullough, Ph.D., CCC-SLP

Kim McCullough, Ph.D., CCC-SLP is an Associate Professor in the Department of Communication Sciences and Disorders at the University of Central Arkansas. She has 17 years experience as a clinician, teacher, and researcher. She teaches courses on aphasia, cognitive-communication disorders, and the neuroscience of communication. Her current research interests include developing clinically efficient assessment and treatment protocols for individuals with cognitive impairments.  


Related Courses

20Q: Mild Cognitive Impairment - The SLP’s Role in Service Delivery
Presented by Kim McCullough, PhD, CCC-SLP, Anne Hunter Cox
Text

Presenters

Kim McCullough, PhD, CCC-SLPAnne Hunter Cox
Course: #10527Level: Intermediate1 Hour
  'The course was a great refresher to my knowledge about MCI'   Read Reviews
Increasingly, SLPs are serving individuals with Mild Cognitive Impairment (MCI). MCI, cognitive reserve, and modifiable risk factors that can reduce the risk of dementia are defined and described in this course. An overview of cognitive/communicative deficits associated with MCI, as well as assessment and management considerations, is also provided.

Mild Cognitive Impairment (MCI): Assessment and Treatment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #11362Level: Introductory1 Hour
  'The information was clear and comprehensive'   Read Reviews
Increasingly, SLPs are serving individuals with Mild Cognitive Impairment (MCI). This session focuses on defining MCI, best practice guidelines for MCI assessment, and best practice guidelines for MCI intervention.

Textbook: Cognitive Communication Disorders of MCI and Dementia - Definition, Assessment, and Clinical Management
Presented by Kim McCullough, PhD, CCC-SLP, Kathryn A. Bayles, PhD, ASHA Fellow, Cheryl Tomoeda, MS, CCC-SLP
Text

Presenters

Kim McCullough, PhD, CCC-SLPKathryn A. Bayles, PhD, ASHA FellowCheryl Tomoeda, MS, CCC-SLP
Course: #10911Level: Intermediate15.5 Hours
  'The information helped distinguish the profiles of different dementias and their relation with cognitive impairment'   Read Reviews
Based on the textbook Cognitive Communication Disorders of MCI and Dementia: Definition, Assessment, and Clinical Management, this course provides the knowledge to diagnose and treat individuals with cognitive-communicative disorders associated with aging, mild cognitive impairment (MCI), and dementia-producing diseases, our fastest growing clinical population.

Treatment of Mild Cognitive Impairment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #8633Level: Intermediate1 Hour
  'Good information on both assessment and treatment strategies for MCI'   Read Reviews
This course will focus on the treatment of MCI using current best practices. Intervention structure and content, as well as examples of strategies and activities for clinical implementation will be reviewed.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'Good comparisons between ALS/ PD with appropriate types of interventions'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.